Suppr超能文献

微小RNA在胆管癌中的新兴作用及其临床意义

The Emerging Role of miRNAs and Their Clinical Implication in Biliary Tract Cancer.

作者信息

Ferreira Martins Nina Nayara, da Silva Oliveira Kelly Cristina, Braga Bona Amanda, de Arruda Cardoso Smith Marília, Ishak Geraldo, Assumpção Paulo Pimentel, Burbano Rommel Rodríguez, Calcagno Danielle Queiroz

机构信息

Núcleo de Pesquisas em Oncologia, Universidade Federal do Pará, Belém, PA, Brazil.

Laboratório de Citogenética Humana, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém, PA, Brazil.

出版信息

Gastroenterol Res Pract. 2016;2016:9797410. doi: 10.1155/2016/9797410. Epub 2016 Dec 27.

Abstract

Biliary tract cancers are aggressive malignancies that include gallbladder cancer and tumors of intra- and extrahepatic ducts and have a poor prognosis. Surgical resection remains the main curative therapy. Nevertheless, numerous patients experience recurrence even after radical surgery. This scenario drives the research to identify biliary tract cancer biomarkers despite the limited progress that has been made. Recently, a large number of studies have demonstrated that deregulated expression of microRNAs is closely associated with cancer development and progression. In this review, we highlight the role and importance of microRNAs in biliary tract cancers with an emphasis on utilizing circulating microRNAs as potential biomarkers. Additionally, we report several single-nucleotide polymorphisms in genes that are associated with the susceptibility of biliary tract tumors.

摘要

胆道癌是侵袭性恶性肿瘤,包括胆囊癌以及肝内和肝外胆管肿瘤,预后较差。手术切除仍然是主要的治愈性疗法。然而,许多患者即使在根治性手术后仍会复发。这种情况推动了对胆道癌生物标志物的研究,尽管进展有限。最近,大量研究表明,微小RNA的表达失调与癌症的发生和发展密切相关。在本综述中,我们重点介绍了微小RNA在胆道癌中的作用和重要性,强调将循环微小RNA作为潜在生物标志物的应用。此外,我们报告了与胆道肿瘤易感性相关基因中的几个单核苷酸多态性。

相似文献

1
The Emerging Role of miRNAs and Their Clinical Implication in Biliary Tract Cancer.
Gastroenterol Res Pract. 2016;2016:9797410. doi: 10.1155/2016/9797410. Epub 2016 Dec 27.
2
Genetic alteration regulated by microRNAs in biliary tract cancers.
Crit Rev Oncol Hematol. 2015 Nov;96(2):262-73. doi: 10.1016/j.critrevonc.2015.05.015. Epub 2015 Jun 4.
3
Circulating MicroRNAs as Biomarkers in Biliary Tract Cancers.
Int J Mol Sci. 2016 May 23;17(5):791. doi: 10.3390/ijms17050791.
4
MicroRNA 141 Expression Is a Potential Prognostic Marker of Biliary Tract Cancers.
Gut Liver. 2016 Sep 15;10(5):836-41. doi: 10.5009/gnl15460.
5
Surgical management of biliary tract cancers.
Chin Clin Oncol. 2016 Oct;5(5):63. doi: 10.21037/cco.2016.10.03.
6
MicroRNA markers for the diagnosis of pancreatic and biliary-tract cancers.
PLoS One. 2015 Feb 23;10(2):e0118220. doi: 10.1371/journal.pone.0118220. eCollection 2015.
7
Non-coding RNAs as emerging molecular targets of gallbladder cancer.
Gene. 2016 Aug 15;588(1):79-85. doi: 10.1016/j.gene.2016.04.047. Epub 2016 Apr 27.
8
9
Tumor progression through epigenetic gene silencing of O(6)-methylguanine-DNA methyltransferase in human biliary tract cancers.
Ann Surg Oncol. 2005 May;12(5):354-63. doi: 10.1245/ASO.2005.07.020. Epub 2005 Mar 31.
10
[Management of biliary tract carcinomas].
Rev Prat. 2009 Apr 20;59(4):469-73.

引用本文的文献

1
Methylation of Tumor Suppressive miRNAs in Plasma from Patients With Pancreaticobiliary Diseases.
Cancer Diagn Progn. 2022 May 3;2(3):378-383. doi: 10.21873/cdp.10120. eCollection 2022 May-Jun.
2
Liquid biopsy provides new insights into gastric cancer.
Oncotarget. 2018 Feb 21;9(19):15144-15156. doi: 10.18632/oncotarget.24540. eCollection 2018 Mar 13.

本文引用的文献

1
Identification of a circulating microRNA signature to distinguish recurrence in breast cancer patients.
Oncotarget. 2016 Aug 23;7(34):55231-55248. doi: 10.18632/oncotarget.10485.
2
The role of microRNAs in gallbladder cancer.
Mol Clin Oncol. 2016 Jul;5(1):7-13. doi: 10.3892/mco.2016.905. Epub 2016 May 11.
3
Genomic Alterations in Biliary Tract Cancer Using Targeted Sequencing.
Transl Oncol. 2016 Jun;9(3):173-8. doi: 10.1016/j.tranon.2016.01.007. Epub 2016 Apr 22.
4
Circulating MicroRNAs as Biomarkers in Biliary Tract Cancers.
Int J Mol Sci. 2016 May 23;17(5):791. doi: 10.3390/ijms17050791.
6
Serum microRNAs as novel biomarkers for primary sclerosing cholangitis and cholangiocarcinoma.
Clin Exp Immunol. 2016 Jul;185(1):61-71. doi: 10.1111/cei.12776. Epub 2016 May 17.
7
microRNAs and Personalized Medicine: Evaluating Their Potential as Cancer Biomarkers.
Adv Exp Med Biol. 2015;888:5-15. doi: 10.1007/978-3-319-22671-2_2.
8
Diagnostic Relevance of microRNAs in Other Body Fluids Including Urine, Feces, and Saliva.
Exp Suppl. 2015;106:245-252. doi: 10.1007/978-3-0348-0955-9_11.
10
MicroRNAs in Serum and Bile of Patients with Primary Sclerosing Cholangitis and/or Cholangiocarcinoma.
PLoS One. 2015 Oct 2;10(10):e0139305. doi: 10.1371/journal.pone.0139305. eCollection 2015.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验